Cheryl Baker Selected Research

Cheryl Baker Research Topics

Disease

10	Neoplasms (Cancer) 11/2016 - 08/2002
6	Neoplasm Metastasis (Metastasis) 05/2014 - 08/2002
4	Pancreatic Neoplasms (Pancreatic Cancer) 11/2016 - 01/2003
2	Colonic Neoplasms (Colon Cancer) 11/2016 - 10/2002
2	Adenocarcinoma 03/2003 - 01/2003
1	Esophageal Neoplasms (Esophageal Cancer) 07/2009
1	Hemorrhage 07/2005
1	Multiple Organ Failure (MODS) 02/2005
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2003
1	Pain (Aches) 06/2003
1	Carcinogenesis 03/2003
1	Colorectal Neoplasms (Colorectal Cancer) 02/2003
1	Infections 01/2003
1	Melanoma (Melanoma, Malignant) 09/2002
1	Prostatic Neoplasms (Prostate Cancer) 08/2002
1	Lymphatic Metastasis 08/2002

Drug/Important Bio-Agent (IBA)

3	Antineoplastic Agents (Antineoplastics)IBA 03/2003 - 09/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2003 - 08/2002
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2003 - 08/2002
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2003 - 08/2002
2	NF-kappa B (NF-kB)IBA 03/2003 - 01/2003
1	PolyketidesIBA 11/2016
1	leiodermatolideIBA 11/2016
1	MacrolidesIBA 11/2016
1	Gemcitabine FDA Link 11/2016
1	Antimitotic AgentsIBA 11/2016
1	dihydromotuporamine CIBA 05/2014
1	tolfenamic acidIBA 07/2009
1	Proteins (Proteins, Gene)FDA Link 07/2009
1	Proto-Oncogene Proteins c-metIBA 07/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2009
1	Sp Transcription FactorsIBA 07/2009
1	MicroRNAs (MicroRNA)IBA 02/2006
1	RibonucleotidesIBA 02/2006
1	acceleratory factor from growth hormone (AcG)IBA 07/2005
1	PKI 166IBA 06/2003
1	ErbB Receptors (EGF Receptor)IBA 06/2003
1	Epidermal Growth Factor (EGF)IBA 06/2003
1	I-kappa B Proteins (I kappa B)IBA 03/2003
1	tartaric acid (tartrate)FDA Link 02/2003
1	SaltsIBA 02/2003
1	becatecarin (XL 119)IBA 02/2003
1	rebeccamycinIBA 02/2003
1	PuromycinIBA 01/2003
1	Interleukin-8 (Interleukin 8)IBA 01/2003
1	Bortezomib (Velcade)FDA Link 01/2003
1	Transcription Factors (Transcription Factor)IBA 01/2003
1	CytokinesIBA 01/2003
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2002
1	Capecitabine (Xeloda)FDA Link 10/2002
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2002
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 09/2002
1	Collagenases (Collagenase)FDA Link 09/2002
1	matrigelIBA 09/2002
1	Immunoglobulin G (IgG)IBA 09/2002
1	AntibodiesIBA 09/2002
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2002
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2002
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 08/2002
1	MitogensIBA 08/2002
1	Matrix Metalloproteinases (MMPs)IBA 08/2002

Therapy/Procedure

3	Therapeutics 02/2003 - 08/2002
2	Drug Therapy (Chemotherapy) 02/2006 - 09/2002
1	Continuous Renal Replacement Therapy 02/2005
1	Activities of Daily Living (ADL) 06/2003
1	Aftercare (After-Treatment) 08/2002